PMID: 2502024Jul 1, 1989Paper

Fetal placental vascular responses to prostacyclin after angiotensin II-induced vasoconstriction

The American Journal of Physiology
V M Parisi, S W Walsh

Abstract

The vasodilator prostacyclin is produced by many fetal tissues and may serve to protect umbilical placental blood flow. We hypothesized that prostacyclin could reverse fetoplacental vasoconstriction produced by angiotensin II (ANG II). Studies were done in eight unanesthetized near-term ovine fetuses. After a control period, ANG II was infused into the fetal inferior vena cava at a rate of 0.5 microgram/min for 40 min. Twenty minutes after starting the ANG II infusion, an infusion of prostacyclin at a rate of 5 micrograms/min was added to the ANG II infusion. Blood flows were measured by the radioactive microsphere technique. Blood flow measurements were made during the control period, 20 min after starting the ANG II infusion, and 20 min after adding prostacyclin to the ANG II infusion. ANG II produced significant fetal hypertension and renal, intestinal, and placental vasoconstriction. Placental vascular resistance rose from 0.14 +/- 0.01 to 0.18 +/- 0.01 mmHg.min.kg fetal wt.ml-1 during the ANG II infusion period (P less than 0.05). The addition of prostacyclin to the ANG II infusion resulted in a return to control values for fetal blood pressure and renal and intestinal resistance. However, placental vasoconstriction was no...Continue Reading

References

May 17, 1979·The New England Journal of Medicine·S Moncada, J R Vane
Nov 1, 1979·American Journal of Obstetrics and Gynecology·T N Tulenko
Jan 1, 1978·Biology of the Neonate·W BermanA M Rudolph
Feb 1, 1989·American Journal of Obstetrics and Gynecology·V M Parisi, S W Walsh
Feb 15, 1985·American Journal of Obstetrics and Gynecology·V M Parisi, J H Rankin
Feb 15, 1985·American Journal of Obstetrics and Gynecology·M LandauerJ H Rankin
Feb 1, 1984·British Journal of Obstetrics and Gynaecology·K K MakA L Boura
Jun 15, 1984·American Journal of Obstetrics and Gynecology·D G GlanceL Myatt
Aug 1, 1982·Prostaglandins·J H RankinD B Schwartz
Jun 28, 1980·British Medical Journal·P J LewisI Downing

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

American Journal of Obstetrics and Gynecology
V M Parisi, J H Rankin
The American Journal of Physiology
B A MeyerV M Parisi
American Journal of Obstetrics and Gynecology
V M Parisi, S W Walsh
American Journal of Obstetrics and Gynecology
V M ParisiE J Stockmar
© 2022 Meta ULC. All rights reserved